3,138 Studies Reviewed. 77.4% Found Biological Effects. The Evidence is Clear.

Extremely low frequency magnetic field modulates the level of neurotransmitters.

Bioeffects Seen

Chung YH, Lee YJ, Lee HS, Chung SJ, Lim CH, Oh KW, Sohn UD, Park ES, Jeong JH. · 2015

View Original Abstract
Share:

Magnetic field exposure significantly altered brain neurotransmitter levels in rats, suggesting EMFs may affect mood and cognitive function.

Plain English Summary

Summary written for general audiences

Researchers exposed laboratory rats to 60 Hz magnetic fields (the same frequency as household electrical systems) for 2 to 5 days and found significant changes in brain chemistry. The magnetic field exposure altered levels of key neurotransmitters including serotonin, dopamine, and norepinephrine across multiple brain regions. These chemical messengers control mood, movement, attention, and other critical brain functions.

Why This Matters

This study provides compelling evidence that extremely low frequency magnetic fields can directly affect brain chemistry at the cellular level. The 2.0 mT exposure level used here is higher than typical household exposures (which range from 0.01 to 0.2 mT), but it's well within levels found near power lines or electrical equipment. What makes this research particularly significant is that it demonstrates measurable changes in neurotransmitter systems that govern mood, cognition, and behavior. The science demonstrates that EMF exposure isn't just about heating tissue or causing cancer. These fields appear to interact with the delicate electrochemical processes that make our brains function. While we need more research to understand the long-term implications, this study adds to a growing body of evidence showing that magnetic fields can influence neurological function in ways we're only beginning to understand.

Exposure Details

Magnetic Field
2 mG
Source/Device
60 Hz
Exposure Duration
2 or 5 days

Exposure Context

This study used 2 mG for magnetic fields:

Building Biology guidelines are practitioner-based limits from real-world assessments. BioInitiative Report recommendations are based on peer-reviewed science. Check Your Exposure to compare your own measurements.

Where This Falls on the Concern Scale

Study Exposure Level in ContextA logarithmic scale showing exposure levels relative to Building Biology concern thresholds and regulatory limits.Study Exposure Level in ContextThis study: 2 mGExtreme Concern5 mGFCC Limit2,000 mGEffects observed in the Severe Concern range (Building Biology)FCC limit is 1,000x higher than this exposure level

Study Details

This study was aimed to observe that extremely low frequency magnetic field (ELF-MF) may be relevant to changes of major neurotransmitters in rat brain

After the exposure to ELF-MF (60 Hz, 2.0 mT) for 2 or 5 days, we measured the levels of biogenic ami...

The exposure of ELF-MF for 2 or 5 days produced significant differences in norepinephrine and vanill...

The present study has demonstrated that exposure to ELF-MFs may evoke the changes in the levels of biogenic amines, amino acid and NO in the brain although the extent and property vary with the brain areas. However, the mechanisms remain further to be characterized.

Cite This Study
Chung YH, Lee YJ, Lee HS, Chung SJ, Lim CH, Oh KW, Sohn UD, Park ES, Jeong JH. (2015). Extremely low frequency magnetic field modulates the level of neurotransmitters. Korean J Physiol Pharmacol. 19(1):15-20, 2015.
Show BibTeX
@article{yh_2015_extremely_low_frequency_magnetic_616,
  author = {Chung YH and Lee YJ and Lee HS and Chung SJ and Lim CH and Oh KW and Sohn UD and Park ES and Jeong JH.},
  title = {Extremely low frequency magnetic field modulates the level of neurotransmitters.},
  year = {2015},
  
  url = {https://synapse.koreamed.org/articles/1026006},
}

Quick Questions About This Study

Researchers exposed laboratory rats to 60 Hz magnetic fields (the same frequency as household electrical systems) for 2 to 5 days and found significant changes in brain chemistry. The magnetic field exposure altered levels of key neurotransmitters including serotonin, dopamine, and norepinephrine across multiple brain regions. These chemical messengers control mood, movement, attention, and other critical brain functions.